University of Illinois team takes top honor at
the University of San Francisco's International Business Plan
March 27, 2006
SAN FRANCISCO (BUSINESS WIRE) -- The University of San
Francisco's annual International Business Plan Competition was
held in San Francisco on March 23-25, 2006. The University of
Illinois at Chicago team, SanoGene Therapeutics, Inc., presented
their plan to develop biopharmaceutical products that prevent
tumor progression and promote cancer cell death to more than fifty
of Silicon Valley's premier venture capitalists, and was awarded
the first place prize of $10,000.00.
"Competition was fierce this year, and I was impressed by
the quality and global reach of the business plans," said
John Denniston, partner, Kleiner Perkins Caufield & Byers.
"USF's global business plan competition is first-rate in
Duke University's Cytex Therapeutics took second place and Remedy
Diagnostics, from the University of Texas at Austin, was awarded
the third place prize. Nineteen semi-finalist teams from the world's
top universities, including London School of Economics, Stanford
University, Hong Kong University of Science & Technology,
and the University of Michigan, presented to more than sixty judges
at the competition, which is regarded by industry insiders and
academic observers as the premier showcase for technology ventures.
Competition judges include partners from top venture firms, such
as: Kleiner Perkins Caufield & Byers, Hummer-Winblad, Intel
Capital, Draper Fisher Jurvetson, Garage Technology Ventures,
Cross Link Capital, De Novo Ventures, and Burrill & Company.
Additionally, attorneys with Wilson Sonsini Goodrich & Rosati,
Hanson Bridgett, and Montgomery Law Group, and executives with
Cisco Systems, Intuit, and T-Mobile/Deutsche Telekom served as
More information regarding the competition and the judges can
be found by visiting the website.